Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clinical course of untreated cervical intraepithelial neoplasia grade 2 under active surveillance: systematic review and meta-analysis
Karoliina Tainio, Antonios Athanasiou, Kari A.O. Tikkinen, et al.
BMJ (2018), pp. k499-k499
Open Access | Times Cited: 309

Showing 1-25 of 309 citing articles:

2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors
Rebecca B. Perkins, Richard S. Guido, Philip E. Castle, et al.
Journal of Lower Genital Tract Disease (2020) Vol. 24, Iss. 2, pp. 102-131
Open Access | Times Cited: 954
Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society
Elizabeth T. H. Fontham, Andrew M. D. Wolf, Timothy R. Church, et al.
CA A Cancer Journal for Clinicians (2020) Vol. 70, Iss. 5, pp. 321-346
Open Access | Times Cited: 795
Cervical Cancer Screening
Rebecca B. Perkins, Nicolas Wentzensen, Richard S. Guido, et al.
JAMA (2023) Vol. 330, Iss. 6, pp. 547-547
Closed Access | Times Cited: 191
The vaginal microbiota associates with the regression of untreated cervical intraepithelial neoplasia 2 lesions
Anita Mitra, David A. MacIntyre, George Ntritsos, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 168
Risk factors for human papillomavirus infection, cervical intraepithelial neoplasia and cervical cancer: an umbrella review and follow-up Mendelian randomisation studies
Sarah Bowden, Triada Doulgeraki, Emmanouil Bouras, et al.
BMC Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 64
Advancing the Fight Against Cervical Cancer: The Promise of Therapeutic HPV Vaccines
Qian Zheng, Misi He, Zejia Mao, et al.
Vaccines (2025) Vol. 13, Iss. 1, pp. 92-92
Open Access | Times Cited: 2
A Phase II, Prospective, Randomized, Multicenter, Open-Label Study of GX-188E, an HPV DNA Vaccine, in Patients with Cervical Intraepithelial Neoplasia 3
Youn Jin Choi, Soo Young Hur, Tae Jin Kim, et al.
Clinical Cancer Research (2019) Vol. 26, Iss. 7, pp. 1616-1623
Open Access | Times Cited: 100
The Natural History of Cervical Intraepithelial Neoplasia Grades 1, 2, and 3: A Systematic Review and Meta-analysis
Diede Loopik, Heidi A. Bentley, Maria N. Eijgenraam, et al.
Journal of Lower Genital Tract Disease (2021) Vol. 25, Iss. 3, pp. 221-231
Closed Access | Times Cited: 88
Human papilloma virus: A review study of epidemiology, carcinogenesis, diagnostic methods, and treatment of all HPV-related cancers
Maryam Soheili, Hossein Keyvani, Marzieh Soheili, et al.
Medical Journal of the Islamic Republic of Iran (2021)
Open Access | Times Cited: 80
The use of host cell DNA methylation analysis in the detection and management of women with advanced cervical intraepithelial neoplasia: a review
WW Kremer, Renske D.M. Steenbergen, DAM Heideman, et al.
BJOG An International Journal of Obstetrics & Gynaecology (2020) Vol. 128, Iss. 3, pp. 504-514
Open Access | Times Cited: 77
Screening for Cervical Cancer
Terresa J. Eun, Rebecca B. Perkins
Medical Clinics of North America (2020) Vol. 104, Iss. 6, pp. 1063-1078
Open Access | Times Cited: 71
Clinical Regression of High-Grade Cervical Intraepithelial Neoplasia Is Associated With Absence of FAM19A4/miR124-2 DNA Methylation (CONCERVE Study)
Wieke W. Kremer, Stèfanie Dick, Daniëlle A.M. Heideman, et al.
Journal of Clinical Oncology (2022) Vol. 40, Iss. 26, pp. 3037-3046
Open Access | Times Cited: 52
Increased human papillomavirus viral load is correlated to higher severity of cervical disease and poorer clinical outcome: A systematic review
Seth‐Frerich Fobian, Xionge Mei, Johannes Crezee, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 6
Closed Access | Times Cited: 9
Predictors for regression and progression of actively surveilled cervical intraepithelial neoplasia grade 2: A prospective cohort study
Laura Bergqvist, Anni Virtanen, Ilkka Kalliala, et al.
Acta Obstetricia Et Gynecologica Scandinavica (2025)
Open Access | Times Cited: 1
Active surveillance of cervical intraepithelial neoplasia grade 2: 2025 British Society of Colposcopy and Cervical Pathology and European Society of Gynaecologic Oncology consensus statement
Maria Kyrgiou, Sarah Bowden, Laura Burney Ellis, et al.
The Lancet Oncology (2025) Vol. 26, Iss. 3, pp. e140-e151
Closed Access | Times Cited: 1
Comparative analysis of photodynamic therapy and conization for cervical high-grade squamous intraepithelial lesion: a systematic review and meta-analysis
Yu Liu, Ruizhen Li, Changzhong Li, et al.
Photodiagnosis and Photodynamic Therapy (2025), pp. 104544-104544
Open Access | Times Cited: 1
Performance of a DNA methylation marker panel using liquid-based cervical scrapes to detect cervical cancer and its precancerous stages
Martina Schmitz, Kristin Eichelkraut, Dana Schmidt, et al.
BMC Cancer (2018) Vol. 18, Iss. 1
Open Access | Times Cited: 74
Methylation in Predicting Progression of Untreated High-grade Cervical Intraepithelial Neoplasia
Karolina Louvanto, Karoliina Aro, Belinda Nedjai, et al.
Clinical Infectious Diseases (2019) Vol. 70, Iss. 12, pp. 2582-2590
Open Access | Times Cited: 72
Can the prophylactic quadrivalent HPV vaccine be used as a therapeutic agent in women with CIN? A randomized trial
Mojgan Karimi‐Zarchi, Leila Allahqoli, Ameneh Nehmati, et al.
BMC Public Health (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 69
The Cochrane HPV vaccine review was incomplete and ignored important evidence of bias
Lars Jørgensen, Peter C Gøtzsche, Tom Jefferson
BMJ evidence-based medicine (2018) Vol. 23, Iss. 5, pp. 165-168
Open Access | Times Cited: 63
p16/ki67 and E6/E7 mRNA Accuracy and Prognostic Value in Triaging HPV DNA-Positive Women
Paolo Giorgi Rossi, Francesca Carozzi, Guglielmo Ronco, et al.
JNCI Journal of the National Cancer Institute (2020) Vol. 113, Iss. 3, pp. 292-300
Open Access | Times Cited: 56
Detection of Host Cell Gene/HPV DNA Methylation Markers: A Promising Triage Approach for Cervical Cancer
Lingyi Zhang, Wenxi Tan, Hongmei Yang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 34
Active surveillance versus treatment in low-risk DCIS: Women’s preferences in the LORD-trial
Renée Schmitz, Ellen G. Engelhardt, Miranda A. Gerritsma, et al.
European Journal of Cancer (2023) Vol. 192, pp. 113276-113276
Open Access | Times Cited: 21
Untreated cervical intraepithelial neoplasia grade 2 and subsequent risk of cervical cancer: population based cohort study
Kathrine Dyhr Lycke, Johnny Kahlert, Lone Kjeld Petersen, et al.
BMJ (2023), pp. e075925-e075925
Open Access | Times Cited: 19
Clinical course of cervical intraepithelial neoplasia grade 2: a population-based cohort study
Kathrine Dyhr Lycke, Johnny Kahlert, Rikke Damgaard, et al.
American Journal of Obstetrics and Gynecology (2023) Vol. 229, Iss. 6, pp. 656.e1-656.e15
Open Access | Times Cited: 18
Page 1 - Next Page

Scroll to top